This is a non-core endpoint: only basic statistics are computed.
Melanocytic naevi of eyelid, including canthus
CD2_BENIGN_MELANOCYTIC_EYELID_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus palpebrae
Similar endpoints
↥List of similar endpoints to
Melanocytic naevi of eyelid, including canthus
based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi of eyelid, including canthus
- Melanocytic naevi
- Melanocytic naevi
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 337 | 228 | 109 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.05 |
| Median age at first event (years) | 52.83 | 49.86 | 59.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 297
- Matched controls
- 2970
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D22.1
ICD-10 Finland
Melanocytic naevi of eyelid, including canthus
10795.4
323.0
284
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
48.3
73.7
89
26
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
19.7
48.3
75
50
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
17.9
17
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
101.2
17.8
19
*
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
10.2
14.8
29
31
2161A
ICD-9 Finland
Benign neoplasm of skin, Eyelid, including canthus[SILMÄLUOMEN BEN KASVAIN, NAEVUS PIGMENTOSUS]
+∞
13.6
13
*
CBA10
NOMESCO Finland
Biopsy of eyelid
42.1
13.3
16
*
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
52.4
13.0
15
*
A04AA02
ATC
granisetron; systemic, transdermal
48.8
12.0
14
*
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
11.8
11.7
21
19
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
11.7
41
99
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
11.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
124.6
11.5
12
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.1
10.5
33
71
130
Kela drug reimbursment
Malignant tumour
+∞
10.5
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.5
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.4
9
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.0
9.0
24
43
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.1
8.8
23
40
H02AB02
ATC
dexamethasone; systemic
9.9
8.4
16
17
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.0
7.7
20
35
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
7.5
53
222
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.7
6.7
48
200
JN4BD
NOMESCO Finland
Extensive body CT
4.4
6.7
23
56
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
4.2
6.5
23
58
HAB40
NOMESCO Finland
Wedge excision of mammary gland
18.5
6.3
9
5
3201
FHL
Removal of a small eyelid tumor in the operating room
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
6.3
6
*
ZZR00
NOMESCO Finland
Flap of skin
27.3
6.3
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
133
2.73
6.35
3.6
1.4
3.8
4.9
ug/l
0.19
27
102
174
1277
1.75
5.95
5.5
3.7
10.5
11.2
umol/l
0.40
165
1192
189
1439
1.71
5.50
8.8
6.2
3.9
4.3
e9/l
1.62
169
1246
243
2002
1.77
5.15
7.5
5.2
77.1
73.9
u/l
0.62
231
1846
116
801
1.68
4.68
3.3
2.0
2.4
2.4
mmol/l
1.08
99
680
119
835
1.66
4.48
3.1
2.2
59.1
56.4
u/l
0.38
112
771
152
1142
1.60
4.31
4.0
3.7
—
—
—
0
0
245
2072
1.67
4.19
4.2
4.0
11.6
10.8
mm/h
0.37
230
1905
136
1012
1.58
3.92
4.7
3.7
36.6
36.4
g/l
0.24
131
939
154
1190
1.54
3.70
5.8
5.6
1.2
1.2
mmol/l
0.43
131
1026
303
2777
1.90
3.22
13.5
11.1
23.7
20.9
mg/l
0.53
244
2104
137
1064
1.48
3.07
5.3
5.3
1.2
1.2
mmol/l
0.02
124
947
91
658
1.52
2.84
2.3
2.4
329.8
7978.9
umol/l
3.38
76
575
180
1495
1.44
2.75
5.3
4.4
6.5
6.6
mmol/l
0.62
166
1359
10
35
2.91
2.32
1.3
1.1
—
—
—
0
0
13
53
2.51
2.30
4.5
4.1
19.2
24.9
mg/l
0.28
13
33
248
2227
1.43
2.20
4.5
4.0
14.9
14.7
pmol/l
0.54
229
2025
286
2643
1.54
2.16
5.3
4.8
1.9
2.3
mu/l
0.51
268
2420
39
252
1.62
1.98
1.5
1.8
—
—
—
0
0
199
1742
1.35
1.93
4.5
4.2
1614.5
1618.7
e6/l
0.00
12
29
71
531
1.43
1.84
1.4
1.3
24.9
36.6
iu/ml
0.57
30
166
38
249
1.59
1.83
1.5
1.8
—
—
—
0
0
61
447
1.45
1.76
3.7
2.0
2.4
2.4
mmol/l
0.06
52
389
12
55
2.23
1.69
1.0
1.3
—
—
—
0
0
69
522
1.40
1.67
1.4
1.3
12.7
9.9
u/ml
0.09
21
207
205
1834
1.30
1.55
3.0
2.9
37.4
41.8
u/l
0.46
195
1704
135
1144
1.30
1.55
2.1
2.2
73.8
78.1
nmol/l
1.17
122
1010
89
715
1.33
1.49
3.9
3.5
0.0
0.0
estimate
0.80
27
227
50
365
1.43
1.48
1.5
1.8
—
—
—
0
0
11
52
2.15
1.46
2.6
1.7
118.2
134.5
g/l
—
6
31
6
22
2.76
1.44
1.2
1.1
—
—
—
0
0
9
42
2.17
1.34
1.2
1.5
—
—
—
0
0
297
2826
1.43
1.32
4.8
4.4
4.7
4.7
mmol/l
0.44
278
2623
13
229
0.55
1.31
3.3
3.1
5.8
5.8
kpa
0.06
13
221
200
1806
1.26
1.31
3.2
3.2
—
—
—
0
0
5
18
2.80
1.29
1.2
1.7
—
—
—
0
0
77
620
1.31
1.26
3.9
3.7
1.0
1.0
kg/l
0.07
13
91
6
25
2.42
1.25
1.2
1.2
—
—
—
0
0
6
25
2.42
1.25
1.2
1.2
—
—
—
0
0
41
299
1.42
1.24
1.8
2.3
23.7
23.9
%
0.03
33
256
6
26
2.33
1.19
1.2
1.2
—
—
—
0
0
6
26
2.33
1.19
1.2
1.2
—
—
—
0
0
6
26
2.33
1.19
1.2
1.2
—
—
—
0
0
18
110
1.67
1.18
5.4
1.5
28.3
29.6
u/ml
0.03
18
105
310
2986
1.48
1.14
11.3
8.5
25.5
24.8
u/l
0.16
300
2867
64
510
1.31
1.13
1.6
1.5
—
—
—
0
0
299
2866
1.38
1.09
5.3
4.9
2.8
2.8
mmol/l
0.04
278
2650
125
1093
1.23
1.03
1.9
2.0
97.3
97.5
pmol/l
0.01
52
541
68
555
1.28
1.01
2.1
1.9
—
—
—
0
0
284
2709
1.31
1.01
4.2
4.0
1.3
1.3
mmol/l
0.05
264
2481
77
639
1.27
1.01
2.0
2.1
2.3
3.0
mg/l
3.07
72
537
76
631
1.26
0.99
1.5
1.5
21.8
21.7
nmol/l
0.02
67
538
293
2809
1.33
0.98
4.6
4.4
1.4
1.5
mmol/l
2.75
275
2597
76
632
1.26
0.98
1.3
1.3
2.7
1.4
u/ml
0.27
21
177
149
1332
1.21
0.98
3.5
3.4
0.0
0.0
estimate
0.00
27
234
7
36
1.96
0.97
1.0
1.3
—
—
—
0
0
274
2609
1.27
0.93
6.0
5.6
39.3
39.5
mmol/mol
0.15
258
2428
6
29
2.09
0.89
1.2
1.1
—
—
—
0
0
8
44
1.84
0.86
2.0
1.7
—
—
—
0
0
275
2628
1.25
0.85
13.3
9.9
81.9
82.2
ml/min/173m2
0.07
231
2106
148
1336
1.19
0.85
4.5
4.7
0.0
0.0
estimate
0.50
29
233
6
31
1.95
0.85
1.2
1.4
—
—
—
0
0
8
46
1.76
0.83
1.4
1.5
—
—
—
0
0
32
243
1.35
0.81
9.2
9.0
2.2
1.5
mmol/l
0.65
25
198
149
1352
1.18
0.79
3.5
3.4
0.0
0.0
estimate
0.50
28
232
6
33
1.83
0.79
1.2
1.1
—
—
—
0
0
6
33
1.83
0.79
1.3
1.5
—
—
—
0
0
32
244
1.34
0.79
3.8
2.7
—
—
—
0
0
25
183
1.40
0.78
1.4
1.6
—
—
—
0
0
75
640
1.22
0.77
4.7
3.9
2.6
2.1
ug/l
0.35
67
564
61
509
1.24
0.77
5.9
3.9
24.9
23.5
%
0.23
30
245
24
175
1.40
0.77
2.0
2.0
0.2
0.2
g/l
0.04
24
161
94
821
1.20
0.77
2.0
2.1
199.9
150.1
u/l
0.36
86
764
6
34
1.78
0.76
1.0
1.1
—
—
—
0
0
6
34
1.78
0.76
1.2
1.1
—
—
—
0
0
6
34
1.78
0.76
1.7
1.1
—
—
—
0
0
9
53
1.72
0.76
1.0
1.4
—
—
—
0
0
5
24
2.10
0.75
1.2
1.5
—
—
—
0
0
7
38
1.86
0.74
3.1
2.0
13.3
13.2
%
—
7
38
7
38
1.86
0.74
1.0
1.0
—
—
—
0
0
7
39
1.81
0.73
1.0
1.1
—
—
—
0
0
5
26
1.94
0.71
1.4
1.4
—
—
—
0
0
99
876
1.18
0.70
2.7
2.9
—
—
—
0
0
40
323
1.27
0.67
28.1
19.5
2.0
1.3
inr
—
5
50
8
129
0.61
0.65
1.8
2.1
1.3
1.2
%
—
8
129
14
95
1.49
0.65
3.4
1.5
297.2
294.4
mu/l
0.01
14
86
134
1225
1.16
0.62
3.0
2.8
169.7
99.1
ug/l
0.43
129
1126
56
480
1.20
0.57
1.5
1.7
1274.6
1177.1
nmol/l
0.32
43
356
286
2775
1.20
0.56
4.5
4.4
5.9
5.9
mmol/l
0.28
267
2527
9
61
1.49
0.54
1.0
1.3
—
—
—
0
0
111
1011
1.15
0.54
3.2
3.3
25.1
81.0
ng/l
0.89
59
674
17
127
1.36
0.50
3.6
2.6
0.1
0.2
e6/l
0.75
17
120
75
667
1.16
0.50
2.5
2.7
0.6
0.5
e6/l
0.13
55
474
10
67
1.51
0.50
2.5
3.2
—
—
—
0
0
7
47
1.50
0.48
1.0
1.1
—
—
—
0
0
10
69
1.46
0.44
1.1
1.3
540.6
431.3
mg/l
—
10
62
18
139
1.31
0.44
1.2
1.6
—
—
—
0
0
26
213
1.24
0.42
1.2
1.2
211.5
139.8
iu/ml
0.38
18
93
24
195
1.25
0.42
1.5
1.3
—
35.4
—
0
13
46
400
1.17
0.42
2.3
2.6
1.2
1.1
e6/l
0.18
27
205
28
232
1.23
0.41
2.1
2.0
29.1
30.7
u/l
0.17
22
190
0
17
0.00
0.41
0.0
2.8
—
636.9
—
0
17
83
756
1.13
0.40
2.7
2.9
951.9
1228.3
ng/l
0.57
71
631
5
34
1.48
0.40
1.0
1.3
43.6
30.3
u/l
—
5
27
8
61
1.32
0.40
1.1
1.1
—
—
—
0
0
36
308
1.19
0.39
1.7
1.7
1.4
1.4
%
0.17
29
269
17
133
1.29
0.39
1.7
1.9
3.2
3.2
mg/l
0.01
11
89
13
98
1.34
0.38
1.8
1.8
—
—
—
0
0
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
58
521
1.14
0.35
1.5
1.4
—
—
—
0
0
14
111
1.27
0.30
5.4
7.8
24.8
25.2
mmol/l
0.30
14
111
25
214
1.18
0.28
2.6
1.9
60.1
66.4
ml/min/173m2
0.56
12
91
12
94
1.29
0.28
1.2
1.4
123.8
214.2
miu/ml
—
6
48
10
76
1.33
0.28
1.6
1.4
—
—
—
0
0
40
357
1.14
0.28
4.0
4.6
31.8
32.5
%
0.15
29
230
55
503
1.11
0.26
4.0
3.7
213.4
391.3
ng/l
0.47
40
371
5
75
0.66
0.26
2.0
1.5
—
—
—
0
0
13
106
1.24
0.23
1.3
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
8
101
0.79
0.21
1.4
2.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
8.4
—
0
13
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
9
114
0.78
0.20
1.7
1.4
—
—
—
0
0
81
768
1.07
0.19
1.8
1.7
1.4
1.4
mmol/l
0.14
69
650
63
592
1.08
0.18
1.6
1.7
1.1
0.9
mg/l
0.31
49
451
7
60
1.17
0.18
1.0
1.6
—
—
—
0
0
12
142
0.84
0.18
1.8
1.3
—
—
—
0
0
110
1057
1.06
0.17
3.6
3.4
—
—
—
0
0
59
555
1.08
0.17
1.4
1.7
423.1
10965356.4
pmol/l
0.50
51
456
37
341
1.10
0.16
6.5
6.5
—
—
—
0
0
82
859
0.94
0.16
4.5
4.0
16.1
11.3
mg/mmol
0.38
51
515
39
361
1.09
0.16
2.4
2.8
4.6
3.2
e6/l
0.29
22
167
13
151
0.86
0.16
1.4
1.5
—
—
—
0
0
16
141
1.14
0.14
2.4
1.9
14.1
13.6
nmol/l
0.09
16
130
14
159
0.88
0.13
1.4
1.5
—
—
—
0
0
11
94
1.18
0.13
1.4
1.4
9.3
10.4
g/l
0.66
11
81
18
161
1.12
0.13
2.1
1.3
—
—
—
0
0
9
109
0.82
0.13
1.6
1.7
—
—
—
0
0
12
105
1.15
0.11
1.3
1.4
—
—
—
0
0
5
46
1.09
0.09
1.8
1.5
—
—
—
0
0
6
55
1.09
0.09
1.3
1.4
—
—
—
0
0
6
56
1.07
0.08
1.0
1.3
—
—
—
0
0
7
68
1.03
0.08
1.3
1.2
—
2.4
—
0
8
11
98
1.13
0.07
1.2
1.7
—
266.7
—
0
6
26
276
0.94
0.07
1.5
1.7
—
—
—
0
0
8
75
1.07
0.07
1.3
1.2
—
31.4
—
0
10
16
147
1.09
0.07
1.1
1.0
—
—
—
0
0
256
2539
1.03
0.07
15.2
12.3
40.5
40.2
%
0.27
183
1838
9
85
1.06
0.07
1.4
1.8
—
—
—
0
0
34
356
0.95
0.07
2.3
2.7
1.0
0.7
ug/l
0.32
22
234
8
94
0.85
0.07
1.0
1.2
—
—
—
0
0
8
94
0.85
0.07
1.0
1.2
—
—
—
0
0
9
102
0.88
0.06
3.6
3.8
25.2
24.3
mmol/l
—
9
91
14
129
1.09
0.05
1.6
1.6
—
—
—
0
0
32
331
0.96
0.03
1.8
1.9
—
—
—
0
0
29
300
0.96
0.03
1.8
1.8
—
—
—
0
0
10
94
1.07
0.01
1.5
1.8
—
—
—
0
0
11
105
1.05
0.00
1.1
1.4
—
—
—
0
0
19
195
0.97
0.00
4.4
6.1
1.6
1.3
mmol/l
0.70
19
188
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
26.7
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
102.6
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
5
55
0.91
0.00
1.6
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
7
75
0.93
0.00
1.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
0.00
1.1
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_EYELID_EXALLC – Melanocytic naevi of eyelid, including canthus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).